SBIR PHASE I TOPIC 406: DEVELOPING AVIDENT HEALTH'S MYNAVIGATOR MHEALTH APPLICATION FOR USE IN PATIENT NAVIGATOR BREAST CANCER CARE WORKFLOWS

SBIR 第一阶段主题 406：开发 Avident Health 的 MYNAVIGATOR MHEALTH 应用程序以用于患者导航乳腺癌护理工作流程

• 批准号: 10267368
• 负责人: TAN LU
• 金额: $ 36.13万
• 依托单位: AVIDENT HEALTH, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-16 至 2021-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10267368
• 关键词: Anxiety; Back; Breast Cancer Patient; Collaborations; Communication; Data; Development; Electronic Health Record; Evaluation; Family Caregiver; Feedback; Focus Groups; Health; Health care facility; Human; Intellectual Property; Knowledge; Legal patent; Methods; Mobile Health Application; Patient Care Team; Patients; Phase; Research Design; Research Institute; Research Methodology; Review Literature; Small Business Innovation Research Grant; Surveys; Testing; cancer care; design; effectiveness testing; heuristics; improved; malignant breast neoplasm; patient engagement; product development; prototype; software development; technological innovation; tool; usability

Avident Health, in partnership with MedStar Health Research Institute (MHRI), will develop the MyNavigator mHealth App and conduct a usability study for breast cancer Patient Navigators (PNs) and their patients. Objectives: (1) develop an Minimum Viable Product (MVP) that increases PN operational efficiencies, facilitates seamless communications, collaboration, and knowledge transfer between PNs, patients, patients’ families, and caregivers; (2) obtain PN, patient, and clinician feedback, and (3) integrate MyNavigator with Electronic Health Records. Specific Aims: (1) establish feasibility as a tool for PNs, (2) build a human-centered design prototype, and (3) test effectiveness among 25+ users. Research Design & Methods rely on Project Management best practices, establishing a need using the York Method for literature reviews, Agile software development for solution development, and heuristic evaluation for usability. Formative and summative testing will be completed upon MVP development at MedStar Health facilities. Technological Innovation includes leveraging Avident’s existing intellectual property, which is protected by two patent applications, and creating a brand new tool to identify and serve the needs of PNs. Expected results: (1) MyNavigator refined utilizing stakeholder focus groups and validated with survey data and quantitative back-end app data. (2) MyNavigator improves communication and patient engagement while reducing cancer care team patient anxiety.

与MedStar Health Research Institute（MHRI）合作，Sventident Health将开发Mynavigator MHealth应用程序，并针对乳腺癌患者导航剂（PNS）及其患者进行可用性研究。目标：（1）开发一种最低可行的产品（MVP），以提高PN运营效率，促进PNS，患者，患者家庭和护理人员之间无缝的通信，协作和知识转移； （2）获取PN，患者和临床反馈，（3）与电子健康记录相结合。具体目的：（1）确定可行性作为PNS的工具，（2）建立一个以人为本的设计原型，以及（3）25个以上用户的测试有效性。研究设计和方法依赖于项目管理的最佳实践，使用约克方法进行文献综述，敏捷软件开发的解决方案开发以及可用性评估的启发式评估。在MEDSTAR健康设施的MVP开发后，将完成形成性和总结性测试。技术创新包括利用Avident的现有知识产权（受两种专利申请保护，并创建一个全新的工具来识别和满足PNS的需求。预期结果：（1）使用利益相关者焦点组精炼Mynavigator，并通过调查数据和定量后端应用数据进行验证。 （2）Mynavigator在减少癌症护理团队患者动画的同时改善了沟通和患者的参与度。